BeOne Medicines Raises FY2026 Sales Guidance from $6.600B-$6.800B to $6.900B-$7.000B vs $6.763B Est
Benzinga Newsdesk 2 weeks ago
NewsGuidance
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
BeOne Medicines (NASDAQ:ONC) raises FY2026 sales outlook from $6.600 billion-$6.800 billion to $6.900 billion-$7.000 billion vs $6.763 billion estimate.
BeOne Medicines (NASDAQ:ONC) raises FY2026 sales outlook from $6.600 billion-$6.800 billion to $6.900 billion-$7.000 billion vs $6.763 billion estimate.
